This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): VY-SOD101
Description: VY-SOD101 is a gene therapy that reduces the level of mutated SOD1 protein in the central nervous system.
Additional information available to subscribers only: